Renal Function and Tenofovir Disoproxil Fumarate for Preexposure Prophylaxis: How Safe Is Safe Enough?
- PMID: 27122594
- PMCID: PMC5021225
- DOI: 10.1093/infdis/jiw169
Renal Function and Tenofovir Disoproxil Fumarate for Preexposure Prophylaxis: How Safe Is Safe Enough?
Keywords: HIV prevention; nephrotoxicity; preexposure prophylaxis; proximal tubules; tenofovir disoproxil fumarate.
Comment on
-
Low Risk of Proximal Tubular Dysfunction Associated With Emtricitabine-Tenofovir Disoproxil Fumarate Preexposure Prophylaxis in Men and Women.J Infect Dis. 2016 Oct 1;214(7):1050-7. doi: 10.1093/infdis/jiw125. Epub 2016 Mar 29. J Infect Dis. 2016. PMID: 27029778 Free PMC article. Clinical Trial.
References
-
- Baeten JM, Celum C. Antiretroviral preexposure prophylaxis for HIV prevention. N Engl J Med 2013; 368:83–4. - PubMed
-
- Thigpen MC, Rose CE, Paxton LA. Antiretroviral preexposure prophylaxis for HIV prevention. N Engl J Med 2013; 368:82–3. - PubMed
-
- Choopanya K, Martin M, Suntharasamai P et al. . Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet 2013; 381:2083–90. - PubMed
-
- US Public Health Service. Preexposure prophylaxis for the prevention of HIV infection in the United States—2014: a clinical practice guideline. http://www.cdc.gov/hiv/pdf/guidelines/PrEPguidelines2014.pdf. Accessed 14 April 2016.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
